300 related articles for article (PubMed ID: 10890743)
1. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
Oualikene W; Lamoureux L; Weber JM; Massie B
Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
[TBL] [Abstract][Full Text] [Related]
2. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
[TBL] [Abstract][Full Text] [Related]
3. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
Krougliak V; Graham FL
Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
[TBL] [Abstract][Full Text] [Related]
4. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
Amalfitano A; Begy CR; Chamberlain JS
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3352-6. PubMed ID: 8622940
[TBL] [Abstract][Full Text] [Related]
5. Designing E1 deleted adenoviral vector by homologous recombination.
Zamani A; Ghannad MS
Iran Biomed J; 2007 Jul; 11(3):199-202. PubMed ID: 18051781
[TBL] [Abstract][Full Text] [Related]
6. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
Hoffmann D; Wildner O
BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
[TBL] [Abstract][Full Text] [Related]
7. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
[TBL] [Abstract][Full Text] [Related]
8. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
[TBL] [Abstract][Full Text] [Related]
9. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.
Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M
J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357
[TBL] [Abstract][Full Text] [Related]
10. Replication-defective bovine adenovirus type 3 as an expression vector.
Reddy PS; Idamakanti N; Chen Y; Whale T; Babiuk LA; Mehtali M; Tikoo SK
J Virol; 1999 Nov; 73(11):9137-44. PubMed ID: 10516020
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region.
Toth K; Kuppuswamy M; Doronin K; Doronina O; Lichtenstein D; Tollefson A; Wold W
Virology; 2002 Sep; 301(1):99-108. PubMed ID: 12359450
[TBL] [Abstract][Full Text] [Related]
12. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
[TBL] [Abstract][Full Text] [Related]
14. A recombinant E1-deleted porcine adenovirus-3 as an expression vector.
Zakhartchouk A; Zhou Y; Tikoo SK
Virology; 2003 Sep; 313(2):377-86. PubMed ID: 12954206
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of adenoviral vectors by flow cytometry.
Weaver LS; Kadan MJ
Methods; 2000 Jul; 21(3):297-312. PubMed ID: 10873484
[TBL] [Abstract][Full Text] [Related]
16. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.
Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A
J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-based libraries: efficient generation of recombinant adenoviruses by positive selection with the adenovirus protease.
Elahi SM; Oualikene W; Naghdi L; O'Connor-McCourt M; Massie B
Gene Ther; 2002 Sep; 9(18):1238-46. PubMed ID: 12215891
[TBL] [Abstract][Full Text] [Related]
18. Human adenovirus type 35: nucleotide sequence and vector development.
Gao W; Robbins PD; Gambotto A
Gene Ther; 2003 Nov; 10(23):1941-9. PubMed ID: 14528318
[TBL] [Abstract][Full Text] [Related]
19. Efficient mobilization of E1-deleted adenovirus type 5 vectors by wild-type adenoviruses of other serotypes.
Rademaker HJ; El Hassan MAA; Versteeg GA; Rabelink MJWE; Hoeben RC
J Gen Virol; 2002 Jun; 83(Pt 6):1311-1314. PubMed ID: 12029145
[TBL] [Abstract][Full Text] [Related]
20. Protease-deleted adenovirus as an alternative for replication-competent adenovirus vector.
Elahi SM; Nazemi-Moghaddam N; Gilbert R
Virology; 2023 Sep; 586():67-75. PubMed ID: 37487327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
